These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1300212)

  • 1. Expanded confidence intervals, one-sided tests, and equivalence testing.
    Bofinger E
    J Biopharm Stat; 1992; 2(2):181-8. PubMed ID: 1300212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-sided hypothesis testing: simultaneous testing of superiority, equivalence and inferiority.
    Goeman JJ; Solari A; Stijnen T
    Stat Med; 2010 Sep; 29(20):2117-25. PubMed ID: 20658478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
    Jennison C; Turnbull BW
    Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43.
    Diletti E; Hauschke D; Steinijans VW
    Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):287-90. PubMed ID: 1526691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative to the use of two-sided tests in clinical trials.
    Dunnett CW; Gent M
    Stat Med; 1996 Aug; 15(16):1729-38. PubMed ID: 8870155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inferential confidence interval method of establishing statistical equivalence that corrects Tryon's (2001) reduction factor.
    Tryon WW; Lewis C
    Psychol Methods; 2008 Sep; 13(3):272-7. PubMed ID: 18778155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple formula for sample size calculation in equivalence studies.
    Zhang P
    J Biopharm Stat; 2003 Aug; 13(3):529-38. PubMed ID: 12921399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size determination for bioequivalence assessment by means of confidence intervals.
    Diletti E; Hauschke D; Steinijans VW
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S51-8. PubMed ID: 1601532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A note on statistical methods for assessing therapeutic equivalence.
    Chow SC; Shao J
    Control Clin Trials; 2002 Oct; 23(5):515-20. PubMed ID: 12392865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On testing equivalence of three populations.
    Wiens BL; Iglewicz B
    J Biopharm Stat; 1999 Aug; 9(3):465-83. PubMed ID: 10473032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C
    Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multivariate test for population bioequivalence.
    Chervoneva I; Hyslop T; Hauck WW
    Stat Med; 2007 Mar; 26(6):1208-23. PubMed ID: 16810712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planning and monitoring of equivalence studies.
    Durrleman S; Simon R
    Biometrics; 1990 Jun; 46(2):329-36. PubMed ID: 2194579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review of statistical procedures for determining the equivalency of two treatments].
    Com-Nougue C; Rodary C
    Rev Epidemiol Sante Publique; 1987; 35(5):416-30. PubMed ID: 3324228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar, the same or just not different: a guide for deciding whether treatments are clinically equivalent. [Dept. of Medicine, Division of Cardiology, Univ. of Western Ontario, London, Ontario].
    Massel D
    Can J Cardiol; 1999 May; 15(5):556-62. PubMed ID: 10350665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43.
    Diletti E; Hauschke D; Steinijans VW
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S59-62. PubMed ID: 1601533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Review and use of decision rules for bioequivalence trials].
    Nicolas P; Tod M; Petitjean O
    Therapie; 1993; 48(1):15-22. PubMed ID: 8356540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choice of student's t- or Wilcoxon-based confidence intervals for assessment of average bioequivalence.
    Hauck WW; Hauschke D; Diletti E; Bois FY; Steinijans VW; Anderson S
    J Biopharm Stat; 1997 Mar; 7(1):179-89. PubMed ID: 9056597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elements of significance testing with equivalence problems.
    Wellek S; Michaelis J
    Methods Inf Med; 1991 Aug; 30(3):194-8. PubMed ID: 1943791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.